Global Bionic Eye Market – Industry Trends and Forecast to 2031

Analyse et taille du marché des yeux bioniques

La restauration de la vision est une application majeure du marché de l'œil bionique, destinée aux personnes souffrant de déficiences visuelles graves ou de cécité. Les yeux bioniques fonctionnent en capturant des informations visuelles via un système de caméra externe, en les traitant et en transmettant des signaux électriques à un réseau microélectronique implanté dans l'œil. Ces signaux stimulent les cellules fonctionnelles restantes de la rétine, contournant efficacement les cellules endommagées ou non fonctionnelles et rétablissant la perception visuelle. Cette technologie offre une nouvelle indépendance et une meilleure qualité de vie aux personnes qui dépendaient auparavant de méthodes alternatives pour les tâches quotidiennes.

Français La taille du marché mondial des yeux bioniques était évaluée à 266,59 millions USD en 2023 et devrait atteindre 523,45 millions USD d'ici 2031, avec un TCAC de 8,80 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché       

Définition du marché

Un œil bionique, également appelé prothèse rétinienne, est un dispositif médical conçu pour restaurer la vision chez les personnes souffrant de déficience visuelle grave ou de cécité. Il se compose généralement d'un système de caméra externe qui capture les informations visuelles. Celles-ci sont traitées et transmises à un réseau microélectronique implanté dans l'œil, stimulant les cellules fonctionnelles restantes de la rétine pour générer une perception visuelle.

Dynamique du marché des yeux bioniques

Conducteurs                                                                                          

• Progrès technologiques croissants

Les avancées dans les domaines de la microélectronique, de la biotechnologie et de la science des matériaux permettent le développement de dispositifs oculaires bioniques plus sophistiqués et plus fiables. La miniaturisation des composants améliore le confort et l'esthétique pour les utilisateurs, tandis que les progrès des algorithmes de traitement d'image améliorent la qualité et la résolution des informations visuelles capturées par des caméras externes. En outre, les améliorations apportées aux systèmes de communication sans fil et de gestion de l'énergie augmentent l'efficacité et la facilité d'utilisation des implants oculaires bioniques. Ces avancées élargissent la base d'utilisateurs potentiels et contribuent à la croissance du marché en augmentant les taux d'adoption et en stimulant les efforts de recherche et développement.

• Initiatives gouvernementales très favorables

Les gouvernements reconnaissent le rôle essentiel des technologies de restauration de la vision dans l’amélioration de la qualité de vie des personnes malvoyantes. C’est pourquoi ils allouent des fonds, des subventions et des ressources pour soutenir la recherche et le développement dans ce domaine. En outre, les organismes de réglementation peuvent simplifier les processus d’approbation des dispositifs oculaires bioniques, facilitant ainsi une entrée plus rapide sur le marché. Ces initiatives encouragent l’innovation et renforcent la confiance des investisseurs, ce qui conduit à une augmentation des investissements dans les entreprises de technologie oculaire bionique.

Opportunités

• Vieillissement de la population

Le risque de développer des troubles de la vision liés à l’âge, tels que la dégénérescence maculaire et la rétinite pigmentaire, augmente avec le vieillissement de la population. Ces pathologies peuvent entraîner de graves déficiences visuelles, voire la cécité. La technologie de l’œil bionique offre une solution prometteuse pour restaurer la vision des personnes touchées par ces maladies oculaires liées à l’âge, répondant ainsi à un besoin pressant d’une population en pleine expansion. Le vieillissement de la population devant continuer à augmenter, la demande d’yeux bioniques comme moyen de restauration de la vision devrait augmenter en conséquence, stimulant la croissance du marché et l’innovation dans ce domaine.

• Sensibilisation croissante des consommateurs

Expanding healthcare infrastructure plays a pivotal role in driving the bionic eye market forward. As healthcare systems evolve and expand, there is increased accessibility to advanced medical technologies, including bionic eye devices and associated services. This expansion enables more individuals with visual impairments to access diagnosis, treatment, and post-operative care related to bionic eye implantation. Moreover, improved healthcare infrastructure facilitates the training of healthcare professionals in the implantation and maintenance of bionic eye systems, ensuring safer and more efficient adoption of this technology. Ultimately, this broader access to healthcare services enhances the market penetration and adoption rates of bionic eye solutions, driving overall market growth.

Restraints/Challenges

• High Cost Constraints

The expenses encompass various aspects, including the cost of device development, surgical procedures for implantation, and post-operative care. For many patients, especially those without adequate insurance coverage, the financial burden of bionic eye treatment can be prohibitive. In addition, healthcare systems may face budgetary constraints that limit their ability to provide widespread access to these expensive devices.

• Limited Awareness

Many individuals with visual impairments may not be aware of the availability of bionic eye technology as a potential treatment option. Similarly, healthcare professionals, including ophthalmologists and optometrists, may lack knowledge about the latest advancements in bionic eye devices and their suitability for certain patients. This lack of awareness hampers early diagnosis, referral, and adoption of bionic eye technology, resulting in missed opportunities for patients to benefit from vision restoration solutions.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In June 2020, Hong Kong University of Science and Technology (HKUST) announced a groundbreaking achievement: the world's first 3D artificial eye. This innovation surpassed existing bionic eye technology, boasting capabilities that even exceeded those of the human eye. Notably, this development promised to bring advanced vision to humanoid robots and offered renewed hope for individuals with visual impairments
• In January 2022, Bionic Vision Technologies (BVT) achieved a significant milestone as Australia's pioneering Bionic Eye System received FDA designation as a Breakthrough Device. This recognition marked a crucial step toward potential FDA approval, highlighting the system's innovative approach and its potential to revolutionize vision restoration technology

Bionic Eye Market Scope

The market is segmented on the basis of type, technology, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• External Eye
• Implanted Eye

Technology  

• Electronic
• Mechanical  

End User

• Hospitals
• Clinics 
• Others

Bionic Eye Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, type, technology, and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate in the market due to the region boasting a robust infrastructure of healthcare facilities, facilitating the adoption and utilization of advanced medical technologies such as bionic eyes. Major industry players have established a significant presence in North America, driving innovation and market growth. In addition, the increasing prevalence of eye diseases in the population fuels the demand for advanced vision restoration solutions.

The Asia-Pacific is expected to substantial expansion in the market. This growth is attributed to various factors, including increased government initiatives fostering awareness, a surge in medical tourism, burgeoning research endeavors, and the presence of vast untapped markets. Additionally, the region's large population base and escalating demand for high-quality healthcare further contribute to the anticipated growth trajectory of the bionic eye market in the Asia-Pacific.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Bionic Eye Market Analysis

The global bionic eye market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the market are:

• Second Sight (U.S.)
• Bionic Vision Technologies (Australia)
• THE BIONIC EYE (U.K)
• PIXIUM VISION (France)
•  Integrated Bionic Microsystems Laboratory (U.S.)
•  NIDEK CO., LTD. (Japan)
•  Optobionics Corporation (U.S.)
•  Biomedical Technologies Inc.(U.S.)
• Monash Vision Group(Australia)
• Nano Retina (Israel)
•  MetaModal LLC (U.S)
•  NEOSTRATA COMPANY, INC.(U.S.)
•  Berlin Heart(Germay)
• ABIOMED(U.S.)
•  Zimmer Biomet(U.S.)
•  eSight (Canada)
• Alpha IMS GmbH (Germany)
• Intelligent Implants GmbH (Germany)
• iBIONICS (Canada)
• IIP Technologies GmbH (Germany)

SKU-61588